Brevan Howard Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,253
Closed -$368K 1078
2024
Q1
$368K Buy
+12,253
New +$368K ﹤0.01% 525